MedTrace Logo

Telerehabilitation Based Motor Relearning Program and Telerehabilitation Based Conventional Physical Therapy in Stroke

NCT07725003 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-07-24

No results posted yet for this study

Summary

This study aims to compare the effects of telerehabilitation based motor relearning program and telerehabilitation based conventional physical therapy on motor function and balance in stroke patients.

Conditions

Interventions

OTHER

Telerehabilitation Based Motor Relearning Program

Participants will receive a Motor Relearning Program (MRP) delivered through secure video conferencing under the supervision of a physiotherapist. The intervention will be provided 3 sessions per week for 6 weeks (18 sessions total). Each session will last 45-60 minutes, including a warm-up, task-specific functional training, and cool-down. Exercises include sitting and standing balance training, trunk control, sit-to-stand practice, upper limb reaching, trunk rotation, weight-shifting, step training, walking practice, stair simulation, obstacle negotiation, dual-task activities, community mobility simulation, and functional transfer training. Exercise intensity will be moderate and progressively increased according to the participant's tolerance and functional performance.

OTHER

Conventional physical therapy

Participants will receive conventional physiotherapy through secure video conferencing under the supervision of a physiotherapist. The intervention will be provided 3 sessions per week for 6 weeks (18 sessions total). Each session will last 45-60 minutes, including a warm-up, exercise session, and cool-down. The program consists of active-assisted and active range-of-motion exercises, stretching, breathing exercises, strengthening exercises, weight-shifting activities, marching in place, gait training, dynamic mobility exercises, and light resistance exercises using Theraband where appropriate. Exercise intensity will be moderate and adjusted according to each participant's tolerance and clinical progress.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Misbah Waris, phd · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-05
Primary Completion
2026-08-06
Completion
2026-08-06

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07725003 on ClinicalTrials.gov